Teigland, Tonje
Igland, Jannicke
Tell, Grethe S.
Haltbakk, Johannes
Graue, Marit
Fismen, Anne-Siri
Birkeland, Kåre I.
Østbye, Truls
Peyrot, Mark
Iversen, Marjolein M.
Article History
Received: 13 December 2021
Accepted: 30 May 2022
First Online: 14 June 2022
Change Date: 14 July 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12902-022-01091-7
Declarations
:
: This research project was conducted in accordance with the Helsinki Declaration. The project received exemption from informed consent from the Regional Committee for Medical and Health Research Ethics, REC North (2014/687). Permissions to use and merge data were obtained from the Norwegian Centre for Research Data (15/01493), the Norwegian Directorate of Health and the Norwegian Institute of Public Health. SSB anonymized the final data file.
: Not applicable.
: KIB has received grants to his institution for lecturing and consulting from AstraZeneca, Novo Nordisk, Sanofi, Lilly, Boehringer Ingelheim and Merck Sharp & Dohme. The other authors have no relevant competing interest to disclose.